Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 8.62%
March 31, 2026 5.57%
December 31, 2025 -31.68%
September 30, 2025 9.38%
June 30, 2025 -37.93%
March 31, 2025 -127.3%
December 31, 2024 -69.92%
September 30, 2024 11.27%
June 30, 2024 7.45%
March 31, 2024 -4.32%
December 31, 2023 10.17%
September 30, 2023 6.00%
June 30, 2023 6.57%
March 31, 2023 3.69%
December 31, 2022 9.14%
September 30, 2022 13.49%
June 30, 2022 16.08%
March 31, 2022 15.19%
December 31, 2021 8.34%
September 30, 2021 10.32%
June 30, 2021 13.74%
March 31, 2021 9.84%
December 31, 2020 7.23%
September 30, 2020 8.27%
June 30, 2020 -3.33%
Date Value
March 31, 2020 -0.38%
December 31, 2019 16.41%
September 30, 2019 6.11%
June 30, 2019 9.87%
March 31, 2019 4.20%
December 31, 2018 3.51%
September 30, 2018 4.59%
June 30, 2018 5.40%
March 31, 2018 2.15%
December 31, 2017 -0.56%
September 30, 2017 5.00%
June 30, 2017 -4.43%
March 31, 2017 -10.83%
December 31, 2016 -0.75%
September 30, 2016 -8.87%
June 30, 2016 -10.22%
March 31, 2016 -41.73%
December 31, 2015 -4.05%
September 30, 2015 -9.34%
June 30, 2015 -8.57%
March 31, 2015 -11.99%
December 31, 2014 -15.34%
September 30, 2014 -14.88%
June 30, 2014 -8.92%
March 31, 2014 -6.74%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 28.46%
Enovis Corp. -0.18%
Stryker Corp. 19.37%
Zimmer Biomet Holdings, Inc. 9.17%
Edwards Lifesciences Corp. 13.87%